№ lp_2_3_31461
The document provides clinical recommendations for adjusting the dose of antiepileptic drugs when co-prescribed with nirmatrelvir/ritonavir, focusing on drug-drug interactions and personalized medicine approaches.
Year: 2021
Region / city: United States, Netherlands, Belgium, Turkey
Topic: Drug interactions, Epilepsy, COVID-19, Antiepileptic drugs
Document Type: Research Article
Organization / Institution: Erasmus MC, KU Leuven, Hacettepe University
Authors: Nadir Yalcin, Karel Allegaert
Target audience: Healthcare professionals, researchers
Period of validity: N/A
Approval date: N/A
Date of changes: N/A
Keywords: SARS-CoV-2, seizure, anticonvulsants, nirmatrelvir, ritonavir, dosing, drug interaction
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.